Clinical trials
Phase 2 Hepatitis C trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2016 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 7 |
| Bristol-Myers Squibb | 6 |
| Debiopharm International SA | 2 |
| Tibotec Pharmaceuticals, Ireland | 2 |
| AbbVie (prior sponsor, Abbott) | 1 |
| Human Genome Sciences Inc. | 1 |
| Kirby Institute | 1 |
| ZymoGenetics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 21 |
| Hepatitis C, Chronic | 5 |
| Chronic Pain | 1 |
| Fibrosis | 1 |
| Hepatitis | 1 |
| Hepatitis, Chronic | 1 |
| Hypertension, Portal | 1 |
| Infections | 1 |
| Liver Diseases | 1 |
| Virus Diseases | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.